Board Meeting Details

  • Meeting scheduled for Thursday, November 5, 2026
  • Primary agenda: Consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026

Other Business Matters

Proposal A: Capital Structure Changes

  • Proposal to increase Authorised Share Capital from existing levels
  • Requires consequential alteration to the Capital Clause of the Memorandum of Association
  • Subject to approval of Board of Directors and shareholders
  • Requires requisite regulatory approvals

Proposal B: Fundraising Options

  • Evaluation of all proposals for raising funds through various instruments:
  • Equity shares
  • Preference shares
  • Fully or partly convertible debentures
  • Non-convertible debentures with warrants
  • Any other equity-based securities
  • Any combination of the above
  • May include green shoe option
  • Potential methods of issuance:
  • Preferential allotment
  • Private placement
  • Qualified Institutions Placement (QIP)
  • One or more tranches/issuances
  • Any other permissible mode
  • Terms and conditions to be determined at Board's absolute discretion
  • Subject to necessary approvals including shareholders/members and regulatory/statutory approvals
  • Ancillary actions for fundraising to be approved